UnannouncedVCRaise

Filed before 2025Filed 27 April 2021

Alimera Sciences Inc raised $10M

Alimera Sciences Inc, a pharmaceuticals company based in Alpharetta, GA, raised $10M in a new equity round, according to a filing dated 27 April 2021.

Raises filed before 2025 are not checked for a public announcement.

Filed
27 April 2021
Round
Equity round
Amount sold
$10M
Offering size
$10M
Investors so far
1
Based in
Alpharetta, GA

Investors on the board

Firms come from the venture funds whose filings name a director of this company.

Who is on the board

2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.

Sign in with Google

How it compares

Larger than 47% of the 2,220 tracked raises with an amount filed in 2021, and than 30% of the 40 in pharmaceuticals.

Alimera Sciences Inc in public filings

FiledFilingSoldRaise
31 May 2023Amended filing$81MAnother raise
7 Apr 2023New filing$12MAnother raise
27 Apr 2021New filing$10MThis raise
18 Feb 2014New filing$37.5MAnother raise

Everything on Alimera Sciences Inc

More with HealthQuest on the board

  1. 83Bar, Inc.$7.5MUnannounced · 260 days31 Dec 2025 · Austin, TX
  2. Solaborate Inc.$47MAnnounced22 Apr 2025 · Clearwater, FL
  3. Venus Concept Inc.$1.1MFiled before 20257 Mar 2024 · Toronto, A6
  4. Home Hospital Newco, Inc.$30MFiled before 202527 Sep 2023 · Minneapolis, MN

All 60 raises

Other unannounced rounds

  1. DVx Atomic Co.$18.5MUnannounced · 1 day16 Sep 2026 · Boston, MA
  2. Aperio Systems, Inc.$1.6MUnannounced · 1 day16 Sep 2026 · Boston, MA
  3. Twin Health, Inc.$59MUnannounced · 1 day16 Sep 2026 · Menlo Park, CA
  4. Scoring Factory AI Inc.$500KUnannounced · 2 days15 Sep 2026 · New York, NY
  5. Royal & Pelham, Inc.$5.4MUnannounced · 2 days15 Sep 2026 · New Orleans, LA
  6. SPECTRA Holdings US, Ltd.$2.5MUnannounced · 2 days15 Sep 2026 · Sandy Springs, GA

All unannounced rounds

Seen it announced?

Send the link and the check will look at it.